PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

DataMEDS AI, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from DataMEDS AI, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Tangible Assets Ratio: Of every $100 the company owns, $13 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 98% of Healthcare companies in United States.
  • Cash Cushion Ratio: Debt, after subtracting cash, is 2.4 times its market value (net debt). Lower than 98% of Healthcare companies in United States.

Where $100 of sales goes

$448Operating costs$20Interest$434Net loss

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

—

Data incomplete

Cash Locked Ratio

—

Data incomplete

Growth quality

Steadiness Ratio

2/3 · 0/3

Sales grew in 2 of the last 3 years; profit grew in 0 of 3.

Less steady than 70% of Healthcare companies in United States.

Growth Efficiency Ratio

—

Sales fell 29%

Sales fell 29% in 3 years, so extra profit per extra sales cannot be measured.

Asset Productivity Ratio

—

Data incomplete

Balance-sheet strength

Debt Due Cover Ratio

-1.0×

Operating cash was negative last year, while some debt falls due within a year.

Higher than 66% of Healthcare companies in United States.

Cash Cushion Ratio

2.4× debt

Debt, after subtracting cash, is 2.4 times its market value (net debt).

Lower than 98% of Healthcare companies in United States.

Tangible Assets Ratio

13%

Of every $100 the company owns, $13 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 98% of Healthcare companies in United States.

Tangible Net Worth Ratio

—

Data incomplete

Shareholders

Shareholder Slice Ratio

+95%

Share count rose 95% in 3 years, so each share's slice of the company became smaller.

Bigger rise in share count than 67% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (11)

DataMEDS AI, Inc. made a loss over the last year. DataMEDS AI, Inc. owes $1.60 for every $1 it owns. DataMEDS AI, Inc. made a loss in each of the last two years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

Loss

DataMEDS AI, Inc. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

-0.53

DataMEDS AI, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.

Market cap

$10 M

The total market value of all of DataMEDS AI, Inc.'s shares at today's price (share price × number of shares), smaller than 87% of Healthcare companies in United States. PosiCap size class: Nano Cap.

Net worth (book value)

Negative

DataMEDS AI, Inc.'s net worth is negative ($20 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.

Owes vs Owns

1.60×

DataMEDS AI, Inc. owes $1.60 for every $1 it owns, so it owes more than it owns, higher than 95% of Healthcare companies in United States.

Dividend yield

None

DataMEDS AI, Inc. does not currently pay a dividend.

Revenue growth

+29%

Revenue rose 29% in the year to Dec 2025, and shrank 11% a year on average over 3 years.

Profit growth

Loss

DataMEDS AI, Inc. made a loss in each of the last two years.

Profit margin

-433.9%

DataMEDS AI, Inc. lost $434 for every $100 of revenue.

Interest cover

Not covered

DataMEDS AI, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.

Cash vs debt

Net debt

DataMEDS AI, Inc. had $25 M more debt than cash (net debt) at Dec 2025.

Questions

How much does DataMEDS AI, Inc. owe compared with what it owns?

DataMEDS AI, Inc. owes $1.60 for every $1 it owns, so it owes more than it owns, higher than 95% of Healthcare companies in United States.

Does DataMEDS AI, Inc. pay a dividend?

No. DataMEDS AI, Inc. does not currently pay a dividend.

Is DataMEDS AI, Inc.'s revenue growing?

Revenue rose 29% in the year to Dec 2025, and shrank 11% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.